Mode
Text Size
Log in / Sign up

Microbial dysbiosis impairs healing of diabetic foot ulcers through reduced diversity and biofilm formationMicrobiome Balance May Help Heal Diabetic Foot Ulcers

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that microbial dysbiosis impairs healing by promoting pathogen biofilms, but large trials are needed for clinical use.

This mini review explores the impact of microbiome dysbiosis on the healing of diabetic foot ulcers and investigates potential therapeutic interventions including probiotics, phage therapy, faecal microbiota transplantation, and traditional Chinese medicine. The authors synthesize findings regarding how reduced skin microbial diversity allows opportunistic pathogens to establish biofilms that resist both host immunity and standard antibiotics.

The review also highlights the gut-skin axis, noting that disturbances in gut microbiota can promote systemic inflammation and metabolic dysfunction, potentially impacting local wound healing. While these mechanisms suggest a role for personalized microbial medicine using multi-omics and AI to match interventions with specific ecotypes, the clinical efficacy of these therapies is not yet established.

A primary limitation noted by the authors is the lack of robust evidence from large-scale trials required for translation into clinical practice. The current findings are based on emerging evidence regarding mechanisms rather than confirmed clinical outcomes.

How this fits prior evidence

This review addresses a gap in management strategies for diabetic foot ulcers, specifically focusing on microbial interventions. It complements existing evidence where temperature-guided prevention is used to reduce the risk of recurrence in patients with diabetic foot ulcers. While it explores the role of probiotics and other microbiome-directed therapies, it notes that clinical efficacy remains unestablished.

Researchers are looking at how the balance of microbes, known as the microbiome, affects the healing of diabetic foot ulcers. When these microbial communities become unbalanced, it is called dysbiosis. This imbalance can reduce the diversity of healthy skin bacteria, which may allow harmful germs to form protective layers that resist both antibiotics and the body's natural defenses.

The study also highlights a link between gut health and skin health. Changes in the gut microbiome can lead to systemic inflammation and issues with metabolism through what is called the gut-skin axis. Because of this connection, therapies like probiotics, phage therapy, and fecal microbiota transplantation are being explored as potential ways to support healing.

It is important to note that these findings come from a review of emerging evidence rather than large clinical trials. While these methods show promise for personalized medicine, more research is needed to confirm how well they work in everyday practice. Patients should talk to their doctors about current treatment options.

What this means for you:
Restoring healthy microbes may help heal diabetic foot ulcers, but more large-scale studies are needed.

Common questions

How does the microbiome affect wound healing?

When the balance of microbes is disrupted, it is called dysbiosis. This can reduce the diversity of healthy skin bacteria. When this happens, harmful germs may form biofilms that are harder for antibiotics and the body's immune system to fight, which can slow down the healing of diabetic foot ulcers.

What role does gut health play in skin issues?

There is a link between the gut and the skin known as the gut-skin axis. Disturbances in the gut microbiota can lead to systemic inflammation and metabolic problems, which may impact how well skin wounds heal.

Are treatments like probiotics proven for foot ulcers?

While options like probiotics, phage therapy, and fecal microbiota transplantation are being studied as potential ways to treat these conditions, they are not yet established in clinical practice. More large-scale trials are needed to confirm their effectiveness before they can be widely recommended.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Diabetic foot ulcers (DFUs) are a serious diabetes-related complication characterized by high rates of amputation and mortality. Emerging evidence suggests that DFUs are not simply the result of infection, but also involve microbiome dysbiosis, which impairs healing. Systemically, disturbances to the gut microbiota via the gut-skin axis promote systemic inflammation and metabolic dysfunction. Locally, skin microbial diversity is significantly reduced, allowing opportunistic pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa to form resilient biofilms. These biofilms resist antibiotics and host immunity, while microbial virulence factors exacerbate tissue damage and disrupt the healing cascade. This synergy between host pathology and dysbiosis perpetuates chronic ulceration. Novel therapeutic strategies therefore aim to modulate this aberrant ecology by shifting from broad-spectrum eradication to targeted restoration. Promising approaches include probiotics, phage therapy, traditional Chinese medicine, and faecal microbiota transplantation, which seek to recalibrate the microbiome and promote healing. However, translation into clinical practice requires more robust evidence from large-scale trials. Future perspectives point towards personalized microbial medicine, integrating multi-omics data and artificial intelligence to match interventions with specific microbial ecotypes, which may reduce the global burden of DFUs.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.